జర్నల్ ఆఫ్ కార్సినోజెనిసిస్ & మ్యూటాజెనిసిస్

నైరూప్య

Opportunities of Intersection for Cancer Genomics and Immunotherapy

Kawarabayasi Y

Cancer is one of the most dangerous disease which made many lives disastrous physically, psychologically and in an unhealthy manner. Major challenge for the scientists and researchers is cancer treatment and still a huge research is going on in clinical trials.

Earlier cancer treatments are surgery, radiation, and chemotherapy are moving to two new effective ways: Cancer genomics and immunotherapy.

Cancer genomics is the study of gene expression, the totality of DNA sequence and differences between tumors cells and normal host cells.

Immuno-oncology is a prominent field that has taken to fight against cancer, provide a refined understanding of how cancer tumors elude the natural immune response. The information on immunology of the host and genomics of tumor will had a drastic growth in the following decade.